- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07637903
Treatment and Prevention of Catheter Related Urinary Tract Infection Use D-mannose
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
New Taipei City, Taiwan, 231
- Taipei Tzu Chi Hospital, Taiwan, R.O.C.
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Patients visit the Urology clinic in Tzu Chi hospital due to long-term catheterization monthly and diagnosed as recurrent UTI last year.
Exclusion Criteria:
- The above patients who unwilling to join this study, patients under 18 years old, women with pregnancy or breastfeeding plans, urological interventions in the past 3 months.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: D-mannose followed by Standard Care
Participants receive D-mannose (one tablet, twice daily) for the first year.
After one year, D-mannose is suspended, and participants receive standard catheter care for the second year.
Follow-up and urine specimen collection occur monthly during scheduled outpatient catheter replacements.
|
Give patients D-mannose, twice a day, one tablet each time, for one year; the research area is divided into two groups, The first group took D-mannose for one year. After the one-year period expired, the use of D-mannose was suspended, and the original standard treatment was resumed treatment, and continued follow-up in the outpatient clinic for one year; the second group maintained the standard treatment for one year, and began to take it after the one-year period expired. Use D-mannose for one year; the grouping method is based on the order of admission of patients in each hospital, with odd-numbered cases in the first group and even-numbered cases in the first group and Second groups. Such patients are fixed in the outpatient clinic to change the urinary catheter every month, so the follow-up time is also arranged during the return visit. Urine specimens were collected at the same time as catheter replacement. |
|
Actieve vergelijker: Standard Care followed by D-mannose
Participants receive standard catheter care for the first year.
After one year, participants receive D-mannose (one tablet, twice daily) for the second year.
Follow-up and urine specimen collection occur monthly during scheduled outpatient catheter replacements.
|
Give patients D-mannose, twice a day, one tablet each time, for one year; the research area is divided into two groups, The first group took D-mannose for one year. After the one-year period expired, the use of D-mannose was suspended, and the original standard treatment was resumed treatment, and continued follow-up in the outpatient clinic for one year; the second group maintained the standard treatment for one year, and began to take it after the one-year period expired. Use D-mannose for one year; the grouping method is based on the order of admission of patients in each hospital, with odd-numbered cases in the first group and even-numbered cases in the first group and Second groups. Such patients are fixed in the outpatient clinic to change the urinary catheter every month, so the follow-up time is also arranged during the return visit. Urine specimens were collected at the same time as catheter replacement. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Number of symptomatic UTIs requiring treatment
Tijdsspanne: Up to 2 years
|
The total number of symptomatic urinary tract infections (UTIs) that required medical treatment during the study period.
|
Up to 2 years
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Incidence of asymptomatic positive bacterial culture
Tijdsspanne: Up to 2 years
|
The number of participants who developed an asymptomatic positive bacterial culture in their urine samples during the study period.
|
Up to 2 years
|
|
Frequency of urinary catheter obstruction
Tijdsspanne: Up to 2 years
|
The total number of urinary catheter obstruction events recorded per participant.
|
Up to 2 years
|
|
Patient and caregiver subjective feelings score
Tijdsspanne: Up to 2 years
|
Subjective feelings and satisfaction assessed by the Global Response Assessment (GRA).
The GRA is a 7-point scale with scores ranging from -3 (markedly worse) to +3 (markedly better).
Higher scores indicate greater symptom improvement and better satisfaction.
|
Up to 2 years
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Shu-Yu Wu, bachelor, Taichung Tzu Chi Hospital
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 10-XD-162
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .